Alimentary pharmacology & therapeutics
-
Aliment. Pharmacol. Ther. · Oct 2013
ReviewReview article: biosimilars are the next generation of drugs for liver and gastrointestinal diseases.
A biosimilar is a copy version of an approved original biological medicine whose data protection has expired. ⋯ Biosimilars represent a new generation of drugs in liver and gastrointestinal diseases. On June 27, 2013, Hospira's Inflectra (INX) was the first biosimilar monoclonal antibody to receive positive opinion from European Medicines Agency's Committee for Medicinal Products for Human Use for rheumatoid arthritis, inflammatory bowel disease and plaque psoriasis.